Back to NBIX
MACKENZIE FINANCIAL CORP → NBIX
MACKENZIE FINANCIAL CORP NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
5
Latest value
$24.6M
Q3 2026
Peak value
$29.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $11.9M |
| Q4 2025 | $10.8M |
| Q1 2026 | $12.1M |
| Q2 2026 | $29.6M |
| Q3 2026 | $24.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $24.6M | 173.2K | — | — |
| Q2 2026 | $29.6M | 175.7K | — | — |
| Q1 2026 | $12.1M | 91.7K | — | — |
| Q4 2025 | $10.8M | 76.8K | — | — |
| Q3 2025 | $11.9M | 84.9K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M